Complete Service
In order to ensure healthcare professionals become “clinically aware” Solutions 4 Snoring has sponsored a series of one-day seminars, undertaken by Dr Ama Johal BDS, M.Sc, PhD, FDS, M.ORTH, FDS(Orth), RCS.Eng. To date more than 600 healthcare professionals have been trained and we anticipate by the end of 2005 there will be circa 700 trained clinicians. The seminars are designed to provide delegates with:
a. Comprehensive overview of sleep-related breathing disorders
b. The importance of recognising signs and symptoms associated with sleep-related breathing disorders, and in particular OSA as a distinct entity from simple snoring
c. The importance of working with sleep clinics
d. The role, design and prescription of MAS
e. The appropriateness of follow-up care.
In addition Solutions 4 Snoring has built a dedicated laboratory focussing on the manufacture of Mandibular and Maxila splints. Previously too many MAS devices were made as a sideline to already busy labs and this gave problems to both the clinicians prescribing and the patients for whom the devices were made. The dedicated S4S lab gives the correct level of support to the clinicians and ultimately the patients.
S4S has also offered trained clinicians a private sleep test option due to the limited resources available within the NHS, as highlighted by the BTS audit (2004). Solutions 4 Snoring has entered into a partnering arrangement with Respironics (UK) Limited to offer Sleep Tests to suspected sufferers of OSA using the “Star Dust” domiciliary sleep test. The cost to the patient is £250+VAT which includes an assessment of the results by a sleep physician.
Respironics (UK) Limited is, one of the UK’s largest respiratory device companies and supplies respiratory or sleep products to all UK NHS trusts and is a leading supplier into the UK private healthcare sector. Respironics provide a full range of diagnostic equipment, CPAP devices for treating the patient, a full range of patient/CPAP interfaces and patient management programmes to ensure the patients are compliant to their therapy.
|